Knockdown assays using siRNAs corresponding to FOXD1 showed that malignant phenotypes (e.g., cell proliferation, migration, and invasive abilities) of HNSCC cells were significantly suppressed. The gene discussed is FOXD1; the disease is head and neck squamous cell carcinoma.